Evidence map›Paper›PMID 37370945›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Dual Deep CNN for Tumor Brain Classification.

Aya M Al-Zoghby, Esraa Mohamed K Al-Awadly, Ahmad Moawad, Noura Yehia, Ahmed Ismail Ebada

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aya M Al-ZoghbyFaculty of Computers and Artificial Intelligence, Damietta University, Damietta 34517, Egypt.
Esraa Mohamed K Al-AwadlyFaculty of Computers and Artificial Intelligence, Damietta University, Damietta 34517, Egypt.ORCID 0000-0001-8839-3600
Ahmad MoawadFaculty of Computers and Artificial Intelligence, Damietta University, Damietta 34517, Egypt.ORCID 0000-0002-1900-4509
Noura YehiaComputer Science Department, Faculty of Computer and Information Science, Mansoura University, Mansoura 35511, Egypt.
Ahmed Ismail EbadaFaculty of Computers and Artificial Intelligence, Damietta University, Damietta 34517, Egypt.ORCID 0000-0002-4478-5853

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumor (BT) is a serious issue and potentially deadly disease that receives much attention. However, early detection and identification of tumor type and location are crucial for effective treatment and saving lives. Manual diagnoses are time-consuming and depend on radiologist experts; the increasing number of new cases of brain tumors makes it difficult to process massive and large amounts of data rapidly, as time is a critical factor in patients' lives. Hence, artificial intelligence (AI) is vital for understanding disease and its various types. Several studies proposed different techniques for BT detection and classification. These studies are on machine learning (ML) and deep learning (DL). The ML-based method requires handcrafted or automatic feature extraction algorithms; however, DL becomes superior in self-learning and robust in classification and recognition tasks. This research focuses on classifying three types of tumors using MRI imaging: meningioma, glioma, and pituitary tumors. The proposed DCTN model depends on dual convolutional neural networks with VGG-16 architecture concatenated with custom CNN (convolutional neural networks) architecture. After conducting approximately 22 experiments with different architectures and models, our model reached 100% accuracy during training and 99% during testing. The proposed methodology obtained the highest possible improvement over existing research studies. The solution provides a revolution for healthcare providers that can be used as a different disease classification in the future and save human lives.

Indexed as

brain tumorsdeep learningdual CNNradiomicsRMItransfer learning

Identifiers

PMID37370945
PMCPMC10297724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.